You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MPN

Showing 26 - 50 of 263
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myeloproliferative Neoplasms (MPN) and COVID-19

Recruiting
  • Myeloproliferative Neoplasm
  • COVID
    • New York, New York
    • +43 more
    Apr 4, 2022

    Graft Vs Host Disease, Peripheral Blood Stem Cell Transplantation, AML Trial in Germany (Cyclophosphamide, ATG)

    Recruiting
    • Graft Vs Host Disease
    • +5 more
    • Augsburg, Germany
    • +15 more
    Aug 2, 2022

    GVHD, AML, ALL Trial in Boston (FLUDARABINE, CYCLOPHOSPHAMIDE, TBI)

    Recruiting
    • GVHD
    • +15 more
    • Boston, Massachusetts
      Massachusetts General Hospital
    Sep 30, 2021

    Leukemia, Myelomonocytic, Chronic Trial in United States (Tipifarnib)

    Completed
    • Leukemia, Myelomonocytic, Chronic
    • Scottsdale, Arizona
    • +7 more
    May 12, 2021

    Epigenetic Age on Clinic-biological Presentation and Prognosis

    Not yet recruiting
    • Myeloproliferative Neoplasm
    • Assessment of the epigenetic age
    • Bordeaux, France
      CHU de Bordeaux, service Hématologie Biologique
    Aug 28, 2023

    Myeloproliferative Tumor, Secondary Leukemia Trial (Multiomic characterization, In vitro drug screening)

    Not yet recruiting
    • Myeloproliferative Neoplasm
    • Secondary Leukemia
    • Multiomic characterization
    • In vitro drug screening
    • (no location specified)
    Aug 28, 2023

    Iron Deficiency Anemia Trial in Australia, Israel, Romania (KER-047)

    Recruiting
    • Iron Deficiency Anemia
    • Adelaide, South Australia, Australia
    • +8 more
    Jun 23, 2023

    Monocytes Sub-populations in Thrombosis Associated With

    Recruiting
    • Myeloproliferative Neoplasm
    • 1 additional tube of blood
    • Bordeaux, France
    • +4 more
    Nov 30, 2022

    PHiladelphia-nEgative Cytogenetic mYeloproliferative Neoplasms.

    Not yet recruiting
    • Myeloproliferative Neoplasm
    • Questionnaire
    • (no location specified)
    May 4, 2020

    Thrombosis in Myeloproliferative Neoplasms

    Completed
    • Myeloproliferative Neoplasm
    • 2 additional tubes of blood
    • Angers, France
    • +23 more
    Aug 17, 2022

    Action of Interferon in Treatment of Myeloproliferative

    Recruiting
    • Myeloproliferative Neoplasm
      • Villejuif, Ile De France, France
        Inserm U1287
      Apr 28, 2023

      Clonal Cytopenia of Undetermined Significance, Essential Thrombocythemia, Myelodysplastic Syndrome Trial in Los Angeles

      Not yet recruiting
      • Clonal Cytopenia of Undetermined Significance
      • +4 more
      • Biospecimen Collection
      • +6 more
      • Los Angeles, California
      • +1 more
      Oct 4, 2023

      MPN Podcast Pilot Study

      Completed
      • Myeloproliferative Neoplasm, Unclassifiable
        • Phoenix, Arizona
          Arizona State University
        Mar 26, 2020

        Thrombotic Complications (CLOJAK)

        Not yet recruiting
        • Myeloproliferative Neoplasm
        • Blood sampling
        • Angers, France
        • +10 more
        Apr 20, 2023

        Myeloproliferative Tumor Trial in Irvine (Diet intervention)

        Completed
        • Myeloproliferative Neoplasm
        • Diet intervention
        • Irvine, California
          University of California, Irvine
        Jun 16, 2022

        Myelodysplastic/Myeloproliferative Tumor, Steroid Refractory GVHD, Allogeneic Hematopoietic Cell Transplant Trial in Toronto

        Completed
        • Myelodysplastic/Myeloproliferative Neoplasm
        • +2 more
        • Decidual stromal cells (DSC)
        • Toronto, Ontario, Canada
          Princess Margaret Cancer Centre
        Jan 8, 2023

        MPN (Myeloproliferative Tumors) Trial in Australia, Canada, United States (itacitinib)

        Completed
        • MPN (Myeloproliferative Neoplasms)
        • Birmingham, Alabama
        • +21 more
        Aug 25, 2021

        MPN (Myeloproliferative Tumors) Trial in Worldwide (Pemigatinib)

        Active, not recruiting
        • MPN (Myeloproliferative Neoplasms)
        • Phoenix, Arizona
        • +32 more
        Jun 24, 2022

        Lung Cancer, Solid Tumor, Gastric Cancer Trial in Denmark, United States (Pemigatinib, Gemcitabine + Cisplatin, Pembrolizumab)

        Completed
        • Lung Cancer
        • +10 more
        • Birmingham, Alabama
        • +19 more
        Jan 4, 2022

        Myelodysplastic/Myeloproliferative Tumors, Adult Trial in Suzhou (venetoclax combined with azacitidine)

        Enrolling by invitation
        • Myelodysplastic/Myeloproliferative Neoplasms
        • Adult
        • venetoclax combined with azacitidine
        • Suzhou, Jiangsu, China
          The First Affiliated Hospital of Soochow University, Jiangsu Ins
        Mar 7, 2022

        Thrombocythemia, Essential, Primary Myelofibrosis Trial in Worldwide (Bomedemstat)

        Enrolling by invitation
        • Thrombocythemia, Essential
        • Primary Myelofibrosis
        • Miami, Florida
        • +18 more
        Jan 30, 2023

        Primary Myelofibrosis, Polycythemia Vera, Essential Thrombocythemia Trial in Toronto (Observational)

        Recruiting
        • Primary Myelofibrosis
        • +9 more
        • Observational
        • Toronto, Ontario, Canada
          Princess Margaret Cancer Centre
        Apr 11, 2022

        Primary Myelofibrosis, Anemia Trial in Worldwide (Luspatercept)

        Completed
        • Primary Myelofibrosis
        • Anemia
        • Phoenix, Arizona
        • +24 more
        Aug 17, 2022

        ph Negative Myeloproliferative Neoplasms: Impact on Outcome and

        Recruiting
        • Myeloproliferative Disease
        • Inflammatory Markers
          • Bari, Italy
          • +10 more
          Oct 21, 2022

          MPN (Myeloproliferative Tumors) Trial in United States (Ruxolitinib, Anagrelide, Placebo)

          Terminated
          Has Results
          • MPN (Myeloproliferative Neoplasms)
          • Phoenix, Arizona
          • +25 more
          Oct 21, 2021